Related Experiment Video
Updated: Aug 31, 2025
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
Hepatic inflammatory myofibroblastic tumor: One case report
Lei Shen1, Zixuan Yang1, Ruibo Ding1
1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Anhui Medical University, Heifei, China.
Frontiers in Surgery
|August 22, 2022
Summary
Hepatic inflammatory myofibroblastic tumor (HIMT) is rare and challenging to diagnose. Surgical resection is effective for HIMT, with necessary follow-up to monitor for recurrence or metastasis.
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Gastroenterology
Background:
- Hepatic inflammatory myofibroblastic tumor (HIMT) is a rare mesenchymal neoplasm with potential for local invasion, metastasis, and recurrence.
- HIMT presents diagnostic challenges due to nonspecific clinical and imaging features.
- Early diagnosis and treatment of HIMT are crucial.
Observation:
- A rare case of HIMT in a 41-year-old female presenting with a liver lesion and fever.
- Surgical intervention was performed after multidisciplinary team discussion.
- Postoperative pathology confirmed the diagnosis of hepatic myofibroblastoma.
Findings:
- Surgical treatment demonstrated efficacy in managing this rare hepatic tumor.
- Literature review indicated limited progress in HIMT diagnosis and treatment.
- The case highlights the importance of surgical resection for HIMT.
Implications:
- Surgical resection should be considered for feasible HIMT cases.
- Postoperative surveillance is essential to detect potential recurrence or metastasis.
- Further research is needed to improve HIMT diagnostic and therapeutic strategies.
